Ikona telefon
Any questions?
+48 570 - 037 - 175
Worldwide delivery options:
Registered post letter - from 12,00 EUR
Registered medium post parcel - from 12,00 EUR
Registered international or - from 12,00 EUR (depends world region you are, 1 - 5 days delivery)
English

English (EN)

find
Sugarcubes
Menu Menu
Your account Your account
Cart Cart
0
Liked products Liked products
0

Lingo - nowy biosensor firmy Abbott nie tylko dla diabetyków?

Will everyone soon be wearing a biosensor that will monitor the level of our indicators and react to changes in real time and inform the health service? Everything indicates that what we saw in futuristic movies will soon become everyday reality.

Abbott chairman and CEO, Robert B. Ford, titled the event "Human-Driven Health: Unlocking Many New Opportunities."

"Technology gives us the ability to digitize, decentralize and advance healthcare beyond measure, create a common language between you and your doctor - and put more control over your health in your hands," said Robert B. Ford. “We are creating a future that will provide you and your loved ones with more personal and precise care. It's happening now. And its potential is nothing less than amazing.”

Lingo i.e. speaking your body's unique language

During the keynote, the company announced it was developing a new category of consumer biosensors called Lingo. They are designed to translate your unique body language into useful data to help you track and measure your overall health and well-being. The sensor technology is designed to track key signals in the body such as glucose, ketones and lactate, and can also be used to track alcohol levels and blood ratios.

"It will be like a window into your body," said Ford. "It's a science you'll have access to at any time so you can understand what your body is telling you and what it needs. Our vision is that Lingo will go far beyond today's health control capabilities to help you proactively manage your health, nutrition and athletic performance."

Lingo extends Abbott's product technology platform that the company pioneered in 2014 for people with diabetes (Freestyle Libre 1 sensors), allowing people to continuously monitor their glucose levels using a small sensor on the back of their arm. Actress and comedian Sherri Shepherd spoke live on the CES stage about how FreeStyle Libre 2 changed her life by giving her glucose readings right on her smartphone so she could make healthier decisions.

Abbott then built a technology platform to develop a product for athletes with the 2020 launch of Libre Sense Glucose Sport Biowearable in Europe. Athletes such as marathon world record holder Eliud Kipchoge use these bio-based garments to optimize the way they fuel their bodies during rigorous training sessions. Lingo aims to extend glucose monitoring to people who want to control their weight, sleep better, improve energy and think more clearly.

Abbott is designing Lingo to measure other biomarkers besides glucose in the future. A device is being developed to continuously track ketones, see how quickly you get into ketosis and understand exactly what keeps you there, providing insights into your diet and weight loss. Work is also underway on a lactate measuring device to track lactate accumulation during exercise - which can be used as an indicator of athletic performance.

Human focus

In addition to people demonstrating the impact of Abbott sensors on people, Mr. Ford was joined on stage by people whose lives have been affected by Abbott devices, partners who came together to ensure a seamless and better life, and other industry visionaries.

Tyrone Morris, a heart failure patient with six months left to live, told the story of how he overcame all odds with three separate Abbott devices: HeartMate 3 iv , CardioMEMS v and an implantable defibrillator. Today, Morris owns a barbecue and food truck catering business in Humble, Texas, where he specializes in low-sodium recipes.

Dr. Fiona Gupta of Mount Sinai Health System in New York highlighted how she uses the NeuroSphere virtual clinic, a first-of-its-kind technology in the U.S. that provides people with deep brain stimulation at a distance, allowing physicians to optimize and tailor treatment over a cellular or Wi-Fi network -Fi, while patients with Parkinson's disease and chronic pain consult them from the comfort of their own living room.

The world is changing before our eyes, and what we used to see in sci-fi movies is gradually being implemented in our everyday lives. Abbott is one of the pioneers of changes in many aspects of medicine and the vision of a biochip that will examine many indicators and parameters in real time is something that is very close.

 

Oprogramowanie sklepu internetowego Sellingo.pl